If
confirmed, the findings will open a new line of research that could ultimately lead to significant innovation, as drugs that control amounts of the novel
mucins or that target specific glycosylating enzymes could lead to a new treatment paradigm for glaucoma.
If
confirmed, the findings will open a new line of research that could ultimately lead to significant innovation, as drugs that control amounts of the novel
mucins could be a new treatment paradigm for glaucoma.